The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids
Will the closing down of smaller hospitals reduce the number of potential trial sites patients can access
Understanding common adverse reactions, serious risks, and appropriate management strategies helps ensure patient wellbeing during treatment
Lifestyle: Do you travel frequently
stop Wegovy immediately and seek urgent medical attention Severe trauma or significant injury preceding the pain Contact your GP urgently or call NHS 111 if experiencing: Severe, unremitting pain that does not respond to simple analgesia or worsens progressively Neurological symptoms including numbness, tingling, or weakness in the legs Fever, night sweats, or unexplained weight loss beyond that expected from Wegovy treatment Known cancer history or other risk factors for metastatic disease Severe morning stiffness lasting more than 30 minutes, particularly in younger patients (possible inflammatory arthropathy) Right upper quadrant pain, fever, or jaundice may indicate gallbladder disease, which is more common during weight loss Reduced urine output with back/flank pain may indicate acute kidney injury, especially if dehydrated from gastrointestinal side effects Patients should also consult their healthcare provider if back pain significantly impairs daily functioning, persists beyond 46 weeks despite conservative management, or if they have concerns about continuing Wegovy treatment
Allow complete drying before lying down
